APPENZELL, Switzerland, May 15 /PRNewswire/ -- Ergonex Pharma today announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to Terguride for the treatment of pulmonary arterial hypertension (PAH). Terguride is currently being evaluated for PAH in a pivotal Phase II trial in Europe.

"The FDA's grant of orphan drug designation to Terguride for PAH encourages and strengthens our development program by offering regulatory, clinical development and commercial benefits," said Dr Rudolf Reiter, CEO of Ergonex Pharma. "We believe that Terguride can provide a significant therapeutic benefit in PAH by inhibiting excess serotonin signalling."

PARIS, May 15 /PRNewswire/ --

- German Federal Chancellor, Angela Merkel, Transport Ministers From More Than 50 Countries, Rajendra Pachauri, Yvo de Boer, Thomas Enders, Hartmut Mehdorn and Other Distinguished Participants...

PARIS, May 15 /PRNewswire/ -- Deezer announces the signing of an agreement with the Universal Music giant covering 35 countries. With this move, the first French music on demand website launches its international deployment in order to position itself as a key player in the changing music industry.

TOKYO, May 15 /PRNewswire/ --

Acrodea, Inc. (CEO and President: Junya Tsutsumi), headquartered in Meguro-ku, Tokyo, and Sony Ericsson Mobile Communications (London UK, President: Hideki Komiyama, "Sony Ericsson") reached an agreement for Acrodea to provide VIVID UI and VIVID Panorama to Sony Ericsson mobile telephones and executed a master license agreement. Based on the agreement, Sony Ericsson will be able to release globally mobile telephone terminals installed with Acrodea products.

About VIVID UI

LONDON, May 15 /PRNewswire/ -- DSG International plc, one of Europe's largest specialist electrical retailers, today announces it's strategic business review. In a video interview Group Chief Executive John Browett talks through the detail of his five point plan for renewal and transformation of the group, which owns brands such as Curry's, PC World, Currys.digital and Pixmania. There will also be a live presentation to analysts at 0900BST.

The interviews, transcript, podcast and vodcast are available now on http://www.cantos.com. Cantos interviews are also available on our CEO Direct page in iTunes.

PERTH, Australia, May 15 /PRNewswire/ --

Professor Lyn Beazley, eminent neuroscientist and Chief Scientist of Western Australia, will conduct a series of workshops, seminars and media interviews in Johannesburg, Durban, Grahamstown and Bloemfontein.

LONDON, May 15 /PRNewswire/ -- The launch of mvision (previously known as Margolis Communication Systems) took place today. Everything about mvision - from the technology itself to its costing structure - is designed to deliver an entirely new kind of video conferencing experience. With mvision, video conferencing is delivered not as a technology or a product, but as a state-of-the-art managed service. The mvision solution runs completely independently of an organisation's main IT network using separate dedicated bandwidth and connectivity, thereby eliminating any technical issues that are commonplace with video conferencing.

GOTHENBURG, Sweden, May 15 /PRNewswire/ -- Albireo, a pharmaceutical company focusing on the development of therapeutics for gastrointestinal diseases, announced today the appointment of Hans Graffner, M.D., Ph.D, as Chief Medical Officer (CMO).

Dr. Graffner will oversee the clinical development programs at Albireo with initial focus on the lead program A3309, a therapeutic with a novel mechanism of action targeting the treatment of patients with chronic constipation.

LONDON, May 15 /PRNewswire/ -- In a video interview, Steve Holliday, National Grid CEO, looks at the group's full year results which include, for the first time, contributions from the Keyspan acquisition. He discusses capital investment plans, the balance sheet and share buy-back and the outlook given the current economic climate. The interview, transcript, podcast and vodcast are available now on http://www.cantos.com. Cantos interviews are also available on our CEO Direct page in iTunes.

LONDON, May 15 /PRNewswire/ --

- With Photo